The EU-FMD ‘Safety Features’ Delegated Act was published on the 9th February and started the 3 year countdown to compliance. This news might have made some companies within the pharma supply chain begin to panic. But don’t, as 3C Excellis Europe can help.
Attending a conference, seminar, or training course is a great opportunity to start overcoming the challenges of pharma serialisation. We’re attending and speaking at several events over the next few months and will be sharing our expertise to help you implement traceability successfully.
This is a truly educational event with no sales presentations and will instead focus on sharing best practice between experts and peers. At the Global Track and Trace Symposium, Christoph will be leading a deep dive review of the EU-FMD requirements and its practical implications at all levels of the pharma supply chain. Additionally on Day 2 we will be holding ‘flying doctor’ sessions and starting you on the road to serialisation success.
Register free today for GTT Europe by emailing contact@globaltrackandtrace.eu
This two day conference is hosted by Systech and will see attendees explore, experience and network with current and potential Systech customers. Christoph is a keynote speaker on day 1 and will be speaking about the changing face of serialization and providing a practical review of the obligations of stakeholders and what lessons can be learnt.
Reserve your seat and hotel for Uniquity Europe
Sharp Packaging Solutions are hosting a short symposium (11am-3pm) on the European Falsified Medicines Directive. Ian and Frederic Menardo will be attending this event to share knowledge with peers on the effects the EU-FMD will have on your company.
Register for Sharp’s Serialisation Symposium
Christoph is speaking at Pharmintech 2016, the exhibition for the pharmaceutical, nutraceutical and personal care industry. This event is a unique innovation and training showcase for the pharmaceutical production chain with exhibitors and speakers focusing on expert solutions and processes.